S16 Ep38: Live Tumor Board: Precision Pathways Transforming Patient Care in Advanced NSCLC
OncLive Podcast
In this podcast, experts Narjust Florez, MD, FASCO; David Carbone, MD, PhD; and Edward Garon, MD, MS; discuss the use of KRAS-, NRG1-, MET-, and ROS1-targeting agents to transform patient care in adva
pharminent
March 27, 2026 (Last updated: March 30, 2026)
OncLive Podcast
In this podcast, experts Narjust Florez, MD, FASCO; David Carbone, MD, PhD; and Edward Garon, MD, MS; discuss the use of KRAS-, NRG1-, MET-, and ROS1-targeting agents to transform patient care in adva
